Specialty Pharmacy

Treatment of elderly patients with multiple myeloma creates unique hurdles for care providers.

Top news of the day from across the health care landscape.

Dual transplant may have a protective role against cellular rejection.

Cancer drugs that inhibit class 1 histone deacetylases may reduce excess enlargement of heart muscle cells.

Targeted interventions to coordinate care could be effective improving the overall patient experience.

HIV knowledge is a significant predictor of the willingness to provide services to patients with HIV.

Drug spending increased 12.6% from 2013 to 2014.

Fourteen orphan drug programs with anti-rheumatic launched over last 30 years.

HIVECä method could improve bladder cancer treatment and save money.

Yoga and aquatic exercise seen to decrease fatigue, depression, and paresthesia in MS patients.

Patients with chronic hepatitis C virus have an increased risk of developing B-cell lymphomas.

Experimental treatment shows promise attacking tumor cells.

Top news of the day from across the health care landscape.

Study finds mutation of TP53 gene impacts effect of chemotherapy in colon cancer patients.

Ineffective antiretroviral regimens, improper dosing, and drug interactions are the most common medication errors in HIV patients.

Sharing genetic and clinical information from cancer patients could allow researchers to better personalize cancer treatments.

Compound in horseradish called glucosinolates found to eliminate cancer-causing free radicals.

Salt-inducible kinases found to limit the production of inflammatory molecules in human immune systems.

Recent advances and updates in oncology and cancer drug development.

Investigational injectable treatment combined with oral direct-acting antiviral drugs shows results after 8 weeks.

Only half of locally advanced rectal cancer patients receive standard therapy, which is affected by demographic factors.

Study finds medication reconciliation reduces error incidence in cancer patients undergoing chemotherapy.

Anavex 2-73, which is already in clinical trials for Alzheimer’s disease, recently received Orphan Drug Designation from the FDA for a rare genetic neurodevelopmental disorder.

Modified common flu adenovirus helps treat drug resistant cancers.

Study may lead to the development of treatments for disorders with damaged myelin sheath.

Individualized treatment for lymphoma may lead to a new standard of care.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the healthcare landscape.